4//SEC Filing
Grossi Federico 4
Accession 0001127602-22-007825
CIK 0001492422other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:15 PM ET
Size
4.4 KB
Accession
0001127602-22-007825
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-03-01$43.53/sh−375$16,324→ 109,811 total
Footnotes (1)
- [F1]This is a scheduled sale from 10B5-1 trading plan.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720634
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:15 PM ET
- Size
- 4.4 KB